The toxic shock syndromes

Infectious Disease Clinics of North America

Volumn 10, Issue 4, 1996, Pages 727-746

  Stevens, D L ^a  

^a Boise VA Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN; CLINDAMYCIN; ERYTHROMYCIN; IMMUNOGLOBULIN; NAFCILLIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

FEMALE; HUMAN; MALE; MENSTRUATION; MULTIPLE ORGAN FAILURE; NOSE RECONSTRUCTION; REVIEW; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; SURGICAL TECHNIQUE; TOXIC SHOCK SYNDROME;

EID: 0030462655     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(05)70324-X     Document Type: Article

References (128)

1. A. Achiron R. Margalit R. Hershkoviz Intravenous immunoglobulin treatment of experimental T cell-mediated autoimmune disease. Upregulation of T-cell proliferation and downregulation of tumor necrosis factor α secretion J Clin Invest 93 1994 600
2. E.M. Adams S. Gudmundsson D.E. Yocum Streptococcal myositis Arch Intern Med 145 1985 1020
3. J.E. Alouf C. Geoffroy The family of the antigenically-related, cholesterol-binding (“sulphydryl-activated”) cytolytic toxins Alouf J.E. Freer J.H. Sourcebook of Bacterial Protein Toxins 1991 Academic Press New York 147
4. S.B. Auerbach B. Schwartz D. Williams Outbreak of invasive group A streptococcal infections in a nursing home. Lessons on prevention and control Arch Intern Med 152 1992 1017
5. W. Barry L. Hudgins S. Donta Intravenous immunoglobulin therapy for toxic shock syndrome JAMA 267 1992 3315
6. T. Bartter A. Dascal K. Carroll “Toxic strep syndrome”: Manifestation of group A streptococcal infection Arch Intern Med 148 1988 1421
7. S. Bavari R.G. Ulrich Staphylococcal enterotoxin A and toxic shock syndrome toxin compete with CD4 for human major histocompatibility complex class II binding Infect Immun 63 1995 423
8. A.G.D. Bean R.A. Freiberg S. Andrade Interleukin 10 protects mice against staphylococcal enterotoxin B–induced lethal shock Infect Immun 61 1993 4937
9. M.S. Bergdoll P.J. Chesney Toxic Shock Syndrome 1991 CRC Press Boca Raton, FL
10. M.S. Bergdoll B.A. Crass R.F. Reiser A new staphylococcal enterotoxin, enterotoxin F, associated with toxic shock syndrome Staphylococcus aureus isolates Lancet 1 1981 1017
11. G.K. Best D.F. Scott J.M. Kling Protection of rabbits in an infection model of toxic shock syndrome (TSS) by a TSS toxin-1–specific monoclonal antibody Infect Immun 56 1988 998
12. M.R. Bibler G.W. Rouan Cryptogenic group A streptococcal bacteremia: Experience at an urban general hospital and review of the literature Rev Infect Dis 8 1986 941
13. A.I. Bisno D.L. Stevens Streptococcal infections in skin and soft tissues N Engl J Med 334 1996 240
14. G.A. Bohach B.N. Kreiswirth R.P. Novick Analysis of toxic shock syndrome isolates producing staphylococcal enterotoxins B and C1 with use of Southern hybridization and immunologic assays Rev Infect Dis 11 1989 S75
15. P.F. Bonventre H. Heeg C. Cullen Toxicity of recombinant toxic shock syndrome toxin 1 and mutant toxins produced by Staphylococcus aureus in a rabbit infection model of toxic shock syndrome Infect Immun 61 1993 793
16. P.F. Bonventre M.R. Thompson L.E. Adinolfi Neutralization of toxic shock syndrome toxin 1 by monoclonal antibodies in vitro and in vivo Infect Immun 56 1988 135
17. P.F. Bonventre L. Weckbach G. Harth Distribution and expression of toxic shock syndrome toxin 1 gene among Staphylococcus aureus isolates of toxic shock syndrome and non–toxic shock syndrome origin Rev Infect Dis 11 1989 S90
18. I. Brook Role of β-lactamase–producing bacteria in the failure of penicillin to eradicate group A streptococci Pediatr Infect Dis J 4 1985 491
19. C.V. Broome Epidemiology of toxic shock syndrome in the United States: Overview Rev Infect Dis 11 1989 S14
20. P.J. Chesney Clinical aspects and spectrum of illness of toxic shock syndrome: Overview Rev Infect Dis 11 1989 S1
21. P.P. Cleary E.L. Kaplan J.P. Handley Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s Lancet 339 1992 518
22. Cleary R, Chen C, Lapenta D, et al: A virulence regulon in Streptococcus pyogenes [abstract 19]. In Program and Abstracts of the Third International American Society for Microbiology conference on Streptococcal Genetics, Minneapolis, 1990, p 12.
23. L.A. Cone D.R. Woodard P.M. Schlievert Clinical and bacteriologic observations of a toxic shock–like syndrome due to Streptococcus pyogenes N Engl J Med 317 1987 146
24. B.A. Crass M.S. Bergdoll Involvement of staphylococcal enterotoxins in nonmenstrual toxic shock syndrome J Clin Microbiol 23 1986 1138
25. B.A. Crass M.S. Bergdoll Toxin involvement in toxic shock syndrome J Infect Dis 153 1986 918
26. J.B. Dale W. Simpson I. Ofek Blastogenic responses of human lymphocytes to structurally defined polypeptide fragments of streptococcal M protein J Immunol 126 1981 1499
27. J.P. Davis P.J. Chesney P.J. Wand Toxic shock syndrome: Epidemiologic features, recurrence, risk factors, and prevention N Engl J Med 303 1980 1429
28. De Azavedo J.C.S. T.J. Foster P.J. Hartigan Expression of the cloned toxic shock syndrome toxin 1 gene (tst) in vivo with a rabbit uterine model Infect Immun 50 1985 304
29. B. Demers A.E. Simor H. Vellend Severe invasive group A streptococcal infections in Ontario, Canada: 1987–1991 Clin Infect Dis 16 1993 792
30. N. Dickgiesser U. Wallach Toxic shock syndrome toxin-1 (TSST-1): Influence of its production by subinhibitory antibiotic concentrations Infect Immunol 15 1996 351
31. Dipersio JR, Define LA, Gardner W, et al: Use of pulsed field gel electrophoresis to investigate the clonal spread of severe Gp A streptococcal disease [abstract (189)]. In Program and Abstracts of the American Society for Microbiology, Washington, DC, 1995, p 33.
32. H. Eagle Experimental approach to the problem of treatment failure with penicillin. I. Group A streptococcal infection in mice Am J Med 13 1952 389
33. A. Efstratiou R.C. George S.E. Holm Report of an informal consultation of directors of WHO collaborating centres on streptococci 1996 World Health Organization Geneva WHO/CDS/BVI/95.6.
34. D.J. Fast P.M. Schlievert R.D. Nelson Toxic shock syndrome–associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production Infect Immun 57 1989 291
35. A.S. Gatanaduy E.L. Kaplan B.B. Huwe Failure of penicillin to eradicate group A streptococci during an outbreak of pharyngitis Lancet 2 1980 498
36. E.T. Gaworzewska G. Coleman Group A streptococcal infections and a toxic shock–like syndrome N Engl J Med 321 1989 1546
37. C.G. Gemmell P.K. Peterson D. Schmeling Potentiation of opsonization and phagocytosis of Streptococcus pyogenes following growth in the presence of clindamycin J Clin Invest 67 1981 1249
38. L.J. Greenberg E.D. Gray E. Yunis Association of HL-A5 and immune responsiveness in vitro to streptococcal antigens J Exp Med 141 1975 934
39. R.N. Greenberg B.G. Willoughby D.J. Kennedy Hypocalcemia and “toxic” syndrome associated with streptococcal fasciitis South Med J 76 1983 916
40. Hackett S, Ferretti J, Stevens D, Cytokine induction by viable Group A streptococci: Suppression by streptolysin O [abstract B-249]. In Program and Abstracts of the American Society for Microbiology, Las Vegas, 1994, p 73.
41. S.P. Hackett P.M. Schlievert D.L. Stevens Cytokine production by human mononuclear cells in response to streptococcal exotoxins Clin Res 39 1991 189A
42. S.P. Hackett D.L. Stevens Streptococcal toxic shock syndrome: Synthesis of tumor necrosis factor and interleukin-1 by monocytes stimulated with pyrogenic exotoxin A and streptolysin O J Infect Dis 165 1992 879
43. S.P. Hackett D.L. Stevens Superantigens associated with staphylococcal and streptococcal toxic shock syndromes are potent inducers of tumor necrosis factor β synthesis J Infect Dis 168 1993 232
44. G. Hallas The production of pyrogenic exotoxins by group A streptococci J Hygiene 95 1985 47
45. A.R. Hauser S.C. Goshorn E. Kaplan Molecular analysis of the streptococcal pyrogenic exotoxins In Programs and Abstracts of the Third International ASM Conference on Streptococcal Genetics 1990 Minneapolis 31
46. S.D. Helgerson L.R. Foster Toxic shock syndrome in Oregon Ann Intern Med 96 1982 909
47. M.L. Hoffmann L.M. Jablonski K.K. Crum Predictions of T-cell receptor– and major histocompatibility complex–binding sites on staphylococcal enterotoxin C1 Infect Immun 62 1994 3396
48. C.W. Hoge B. Schwartz D.F. Talkington The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock–like syndrome JAMA 269 1993 384
49. Hohenboken JJ, Anderson F, Kaplan EL, Invasive Group A streptococcal (GAS) serotype M-1 outbreak in a long-term care facility with mortality [abstract J 189]. In Programs and Abstracts of the 26th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, 1994, p 192.
50. S.E. Holm A. Norrby A.M. Bergholm Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988–1989 J Infect Dis 166 1992 31
51. V. Hribalova Streptococcus pyogenes and the toxic shock syndrome Ann Intern Med 108 1988 772
52. M. Iwasaki H. Igarashi Y. Hinuma Cloning, characterization and overexpression of a Streptococcus pyogenes gene encoding a new type of mitogenic factor FEBS Lett 331 1993 187
53. J.A. Jacobson E. Kasworm J.A. Daly Risk of developing toxic shock syndrome associated with toxic shock syndrome toxin 1 following nongenital staphylococcal infection Rev Infect Dis 11 1989 S8
54. D.R. Johnson D.L. Stevens E.L. Kaplan Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis J Infect Dis 166 1992 374
55. L.P. Johnson M.A. Tomai P.M. Schlievert Bacteriophage involvement in group A streptococcal pyrogenic exotoxin A production J Bacteriol 166 1986 623
56. V. Kappur M.W. Majesky L.L. Li Cleavage of interleukin 1B (IL-1B) precursor to produce active IL-1B by a conserved extracellular cysteine protease from Streptococcus pyogenes. Proc Natl Acad Sci USA 90 1993 7676
57. Kaul R, McGeer, Norrby-Teglund A, et al: Intravenous immunoglobulin therapy in streptococcal toxic shock syndrome: Results of a matched case-controlled study [abstract LM68]. In Programs and Abstracts of the 35th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, 1995, p 339.
58. Y. Kawabe A. Ochi Programmed cell death and extrathymic reduction of Vβ8+ CD4 T cells in mice tolerant to Staphylococcus aureus enterotoxin B Nature 349 1991 245
59. K.S. Kim E.L. Kaplan Association of penicillin tolerance with failure to eradicate group A streptococci from patients with pharyngitis J Pediatr 107 1985 681
60. W. Kohler Streptococcal toxic shock syndrome Int J Med Microbiol Virol Parasitol Infect Dis 272 1990 257
61. W. Kohler D. Gerlach H. Knoll Streptococcal outbreaks and erythrogenic toxin type A Int J Med Microbiol 266 1987 104
62. M. Kotb M. Tomai G. Majumdar Cellular and biochemical responses of human T lymphocytes stimulated with streptococcal M protein In XI Lancefield International Symposium on Streptococcal Diseases 1990 Sienna Italy
63. T. Krakauer Costimulatory receptors for the superantigen staphylococcal enterotoxin B on human vascular endothelial cells and T cells J Leukoc Biol 56 1994 458
64. T. Krakauer Inhibition of toxic shock syndrome toxin-1–induced cytokine production and T-cell activation by interleukin-10, interleukin-4, and dexamethasone J Infect Dis 172 1995 988
65. B.N. Kreiswirth S.J. Projan P.M. Schlievert Toxic shock syndrome toxin 1 is encoded by a variable genetic element Rev Infect Dis 11 1989 S83
66. R.C. Lancefield Current knowledge of type specific M antigens of Group A streptococci J Immunol 89 1962 307
67. R.H. Latham M.W. Kehrberg J.A. Jacobson Toxic shock syndrome in Utah: A case-control and surveillance study Ann Intern Med 96 1982 906
68. H.R. MacDonald S. Baschieri R.K. Lees Clonal expansion precedes anergy and death of Vβ8+ peripheral T cells responding to staphylococcal enterotoxin B in vivo Eur J Immunol 21 1991 1963
69. P. Marrack J.W. Kappler The staphylococcal enterotoxins and their relatives Science 248 1990 705
70. P.R. Martin E.A. Hoiby Streptococcal serogroup A epidemic in Norway 1987–1988 Scand J Infect Dis 22 1990 421
71. J.E. McCormack J.E. Callahan J. Kappler Profound deletion of mature T cells in vivo by chronic exposure to exogenous superantigen J Immunol 150 1993 3785
72. McGeer K, Green R, Cann D, Changing epidemiology of invasive group A streptococcal infections—population-based surveillance, Ontario, Canada, 1992–1995 [abstract K135]. In Program and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, 1995, p 312.
73. Melish ME, Frogner KS, Hirata SA, Murata MS, Human gamma globulin therapy in experimental toxic shock syndrome (TSS) [abstract B194]. In Program and Abstracts of the American Society for Microbiology, Atlanta, 1987, p 57.
74. T. Miethke C. Wahl K. Heeg Acquired resistance to superantigen-induced T-cell shock. Vβ selective T-cell unresponsiveness unfolds directly from a transient state of hyperreactivity J Immunol 150 1993 3776
75. Mittag H.-C. Toxic Shock Syndrome and the Other Staphylococcal Toxicoses 1988 Schattauer Stuttgart
76. J.A. Mollick G.G. Miller J.M. Musser A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C J Clin Invest 92 1993 710
77. J.A. Mollick R.R. Rich Characterization of a superantigen from a pathogenic strain of Streptococcus pyogenes. Clin Res 39 1991 213A
78. H. Muller-Alouf J.E. Alouf D. Gerlach Comparative study of cytokine release by human peripheral blood mononuclear cells stimulated with Streptococcus pyogenes superantigenic erythrogenic toxins, heat-killed streptococci, and lipopolysaccharide Infect Immun 62 1994 4915
79. D.L. Murray D.H. Ohlendorf P.M. Schlievert Staphylococcal and streptococcal superantigens: Their role in human diseases American Society for Microbiology News 61 1995 229
80. J.M. Musser A.R. Hauser M.H. Kim Streptococcus pyogenes causing toxic-shock–like syndrome and other invasive diseases: Clonal diversity and pyrogenic exotoxin expression Proc Natl Acad Sci USA 88 1991 2668
81. S.K. Nida J.J. Ferretti Phage influence on the synthesis of extracellular toxins in group A streptococci Infect Immun 36 1982 745
82. Norrby-Teglund A, Kaul R, Low DE, et al: Intravenous immunoglobulin and superantigen-neutralizing activity in streptococcal toxic shock syndrome patients. In 35th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, 1995.
83. A. Norrby-Teglund D. Newton M. Kotb Superantigenic properties of the group A streptococcal exotoxin SpeF (MF) Infect Immun 66 1994 5227
84. A. Norrby-Teglund M. Norgren S.E. Holm Similar cytokine induction profiles of a novel streptococcal exotoxin, MF, and pyrogenic exotoxins A and B Infect Immun 62 1994 3731
85. M.T. Osterholm J.P. Davis R.W. Gibson Tri-state toxic-shock syndrome study. I. Epidemiologic findings J Infect Dis 145 1982 431
86. M.T. Osterholm J.C. Forfang Toxic shock syndrome in Minnesota: Results of an active-passive surveillance system J Infect Dis 145 1982 458
87. J. Parsonnet Z.A. Gillis A.G. Richter A rabbit model of toxic shock syndrome that uses a constant, subcutaneous infusion of toxic shock syndrome toxin 1 Infect Immun 55 1987 1070
88. Parsonnet J, Modern PA, Giacobbe K, Effect of subinhibitory concentrations of antibiotics on production of toxic shock syndrome toxin-1 (TSST-1) [abstract 29]. In Program and Abstracts of the 32nd Meeting of the Infectious Disease Society of America, Orlando, 1994, p 6A
89. D.B. Petitti A.L. Reingold J. Chin The incidence of toxic shock syndrome in northern California: 1972–1983 JAMA 255 1986 368
90. J.K. Rasheed R.J. Arko J.C. Feeley Acquired ability of Staphylococcus aureus to produce toxic shock–associated protein and resulting illness in a rabbit model Infect Immun 47 1985 598
91. T.M. Rotch Pediatrics: The Hygienic and Medical Treatment of Children 1896 J.B. Lippincott Company Philadelphia
92. W.F. Schlech K.N. Shands A.L. Reingold Risk factors for the development of toxic shock syndrome: Association with a tampon brand JAMA 248 1982 835
93. P.M. Schlievert Staphylococcal enterotoxin B and toxic shock syndrome toxin 1 are significantly associated with non-menstrual TSS Lancet 1 1986 1149
94. P.M. Schlievert K.N. Shands B.B. Dan Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome J Infect Dis 143 1981 509
95. B. Schwartz J.A. Elliot J.C. Butler Clusters of invasive group A streptococcal infections in family, hospital, and nursing home settings Clin Infect Dis 15 1992 277
96. D.F. Scott J.M. Kling J.J. Kirkland Characterization of Staphylococcus aureus isolates from patients with toxic shock syndrome, using polyethylene infection chambers in rabbits Infect Immun 39 1983 383
97. R.H. See W.W.S. Kum A.H. Chang Induction of tumor necrosis factor and interleukin-1 by purified staphylococcal toxic shock syndrome toxin 1 requires the presence of both monocytes and T lymphocytes Infect Immun 60 1992 2612
98. K.N. Shands G.P. Schmidt B.B. Dan Toxic shock syndrome in menstruating women N Engl J Med 303 1980 1436
99. T. Shimozato M. Iwata N. Tamura Suppression of tumor necrosis factor α production by a human immunoglobulin preparation for intravenous use Infect Immun 58 1990 1384
100. W.E. Stamm J.C. Feeley R.R. Facklam Wound infections due to group A streptococcus traced to a vaginal carrier J Infect Dis 138 1978 287
101. B. Stegmayr S. Bjorck S. Holm Septic shock induced by group A streptococcal infections: Clinical and therapeutic aspects Scand J Infect Dis 24 1992 589
102. D.L. Stevens Invasive group A streptococcus infections Clin Infect Dis 14 1992 2
103. D.L. Stevens Invasive group A streptococcal infections: The past, present, and future Pediatr Infect Dis J 13 1994 561
104. D.L. Stevens Could nonsteroidal anti-inflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome? Clin Infect Dis 21 1995 977
105. D.L. Stevens A.E. Bryant S.P. Hackett Gram-positive shock Curr Opin Infect Dis 5 1992 355
106. D.L. Stevens A.E. Bryant S.P. Hackett Antibiotic effects on bacterial viability, toxin production, and host response Clin Infect Dis 20 1995 S154
107. D.L. Stevens A.E. Bryant S.P. Hackett Group A streptococcal bacteremia: The role of tumor necrosis factor in shock and organ failure J Infect Dis 173 1995 619 626
108. D.L. Stevens A.E. Bryant S. Yan Invasive group A streptococcal infection: New concepts in antibiotic treatment Int J Antimicrob Agents 4 1994 297
109. D.L. Stevens A.E. Bryant S. Yan Factors controlling host range and pathogenesis of group A streptococcal infections Verduin C.M. Watson D.A. van Dijk H. Constitutional Resistance to Infection 1995 RG Landes Austin, TX 15
110. D.L. Stevens A.E. Gibbons R. Bergstrom The Eagle effect revisited: Efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis J Infect Dis 158 1988 23
111. D.L. Stevens K.A. Maier J.E. Mitten Effect of antibiotics on toxin production and viability of Clostridium perfringens. Antimicrob Agents Chemother 31 1987 213
112. D.L. Stevens M.H. Tanner J. Winship Reappearance of scarlet fever toxin A among streptococci in the Rocky Mountain West: Severe group A streptococcal infections associated with a toxic shock–like syndrome N Engl J Med 321 1989 1
113. D.L. Stevens S. Yan A.E. Bryant Penicillin binding protein expression at different growth stages determines penicillin efficacy in vitro and in vivo: An explanation for the inoculum effect J Infect Dis 167 1993 1401
114. D. Stevens Streptococcal toxic shock syndrome: Spectrum of disease, pathogenesis, and new concepts in treatment Emerging Infectious Diseases 1 1995 69
115. J. Todd M. Fishaut Toxic-shock syndrome associated with phage-group-1 staphylococci Lancet 2 1978 1116
116. J.K. Todd Therapy of toxic shock syndrome Drugs 39 1990 856
117. J.K. Todd A.M. Wiesenthal M. Ressman Toxic shock syndrome. II. Estimated occurrence in Colorado as influenced by case ascertainment methods Am J Epidemiol 122 1985 857
118. T.D. Valenzuela T.M. Hooton E.L. Kaplan Transmission of `toxic strep' syndrome from an infected child to a firefighter during CPR Ann Emerg Med 20 1991 1 123
119. L.G. Veasy S.E. Wiedmeier G.S. Orsmond Resurgence of acute rheumatic fever in the intermountain area of the United States N Engl J Med 316 1986 421
120. Wannamaker L.W. Rammelkamp C.H. Jr F.W. Denny Prophylaxis of acute rheumatic fever by treatment of the preceding streptococcal infection with various amounts of depot penicillin Am J Med 10 1951 673
121. R. Watanabe-Ohnishi D.E. Low A. McGeer Selective depletion of Vβ-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome J Infect Dis 171 1995 74
122. L. Weinstein M. Barza Gas gangrene N Engl J Med 289 1972 1129
123. D.E. Wexler R.D. Nelson P.P. Cleary Human neutrophil chemotactic response to group A streptococci: Bacteria-mediated interference with complement-derived factors Infect Immun 39 1983 239
124. The Working Group on Severe Streptococcal Infections Defining the group A streptococcal toxic shock syndrome: Rationale and consensus definition JAMA 269 1993 390
125. S. Yan G.A. Bohach D.L. Stevens Persistent acylation of high–molecular weight penicillin binding proteins by penicillin induces the post-antibiotic effect in Streptococcus pyogenes J Infect Dis 170 1994 609
126. S. Yan P.M. Mendelman D.L. Stevens The in vitro antibacterial activity of ceftriaxone against Streptococcus pyogenes is unrelated to penicillin-binding protein 4 FEMS Microbiol Lett 110 1993 313
127. J.M. Yong Necrotising fasciitis Lancet 343 1994 1427
128. J.B. Zabriskie D. Lavenchy R.C.J. Williams Rheumatic fever–associated B-cell alloantigens as identified by monoclonal antibodies Arthritis Rheum 28 1985 1047